Last update 21 Nov 2024

Adipose-derived autologous stem cell therapy (U.S. Stem Cell)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
AdipoCell (Bioheart), Bioheart Acute Cell Therapy, Implanted autologous adiposederived stem cells U.S. Stem Cell
+ [1]
Target-
Mechanism
Cell replacements
Therapeutic Areas
Skin and Musculoskeletal DiseasesCardiovascular DiseasesImmune System Diseases+ [3]
Active Indication-
Inactive Indication
Coronary DiseaseErectile DysfunctionHeart Failure+ [6]
Originator Organization
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
Active Organization-
Inactive Organization
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.Revita Life SciencesMagnum Cell Therapies
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Adipose-derived autologous stem cell therapy (U.S. Stem Cell)
NCT02742857 / CompletedPhase 1
Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multimodality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury
100 Clinical Results associated with Adipose-derived autologous stem cell therapy (U.S. Stem Cell)
Login to view more data
100 Translational Medicine associated with Adipose-derived autologous stem cell therapy (U.S. Stem Cell)
Login to view more data
100 Patents (Medical) associated with Adipose-derived autologous stem cell therapy (U.S. Stem Cell)
Login to view more data
100 Deals associated with Adipose-derived autologous stem cell therapy (U.S. Stem Cell)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Intervertebral Disc DegenerationPhase 2
US
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
06 Mar 2014
Heart FailurePhase 2
MX
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
24 Jul 2010
Coronary DiseasePhase 2
VE
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
Erectile DysfunctionPhase 2-
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
Knee InjuriesPhase 2
US
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
Myocardial InfarctionPhase 2
US
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
OsteoarthritisPhase 2
IN
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
PsoriasisPhase 2-
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
Pulmonary Disease, Chronic ObstructivePhase 2
MX
U.S. Stem Cell, Inc.U.S. Stem Cell, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free